Telehealth company
Brello Health
Official homepage, about, and FAQ pages reviewed
Unclaimed profileReviewed Aug 2, 2026
Telehealth service profile
- Care model
- Self-pay telehealth plans with a provider-led health review intake, ongoing provider and customer support, and bundled fitness and nutrition classes
- Medication access
- Compounded tirzepatide, semaglutide, NAD+, sermorelin, and MICC, with bundles combining GLP-1, NAD+, and sermorelin; reviewed pages disclose compounded products are not FDA-approved.
- Provider model
- A healthcare provider reviews the intake form and approves prescriptions; provider support and customer service continue through treatment.
- Pharmacy pathway
- A USA-based 503A partner pharmacy fulfills and ships approved medications, with estimated 2-3 business day shipping when approved and a published state shipping map.
- Insurance support
- Reviewed pages present transparent self-pay pricing and do not advertise insurance billing.
- Availability
- Shipping times vary by state during the pharmacy facility transition; plans auto-renew every 11 weeks until cancelled.
Editorial record
Reviewed pages advertise plans starting at $79 per month billed as 3-month supplies with an 11-week renewal cycle, a USA-based 503A partner pharmacy, and a live notice that the partner pharmacy is transitioning to a larger facility with temporary shipping delays tracked on a state map.
Profile ownership: unclaimed. Company representatives will be able to propose identity and catalog updates without changing editorial or regulatory records.